Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 22.11M | 23.99M | 36.18M | 32.84M | 36.34M |
Gross Profit | -1.88M | 8.01M | 13.08M | 10.30M | 4.05M |
EBITDA | -835.00K | -5.66M | -16.62M | 4.86M | -16.43M |
Net Income | -6.76M | -12.33M | -28.14M | -8.60M | -39.13M |
Balance Sheet | |||||
Total Assets | 24.98M | 17.94M | 24.79M | 34.62M | 39.88M |
Cash, Cash Equivalents and Short-Term Investments | 13.86M | 2.39M | 1.88M | 1.11M | 1.52M |
Total Debt | 31.16M | 40.48M | 43.46M | 40.24M | 82.92M |
Total Liabilities | 79.83M | 89.88M | 87.54M | 101.77M | 172.28M |
Stockholders Equity | -50.86M | -67.11M | -54.77M | -58.90M | -122.72M |
Cash Flow | |||||
Free Cash Flow | -5.81M | -6.29M | -29.83M | -12.73M | 2.49M |
Operating Cash Flow | -5.81M | -6.13M | -29.77M | -12.37M | 2.58M |
Investing Cash Flow | 73.00K | -331.00K | -65.00K | -363.00K | 269.00K |
Financing Cash Flow | 17.20M | 6.99M | 30.61M | 12.50M | -3.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | HK$26.79B | 10.55 | 11.12% | 6.58% | -6.53% | -18.43% | |
56 Neutral | $7.08B | 5.28 | -5.20% | 5.56% | 8.18% | -38.45% | |
46 Neutral | €147.23M | ― | -9.22% | ― | -5.75% | 57.80% | |
46 Neutral | HK$30.35M | ― | -4.12% | ― | 0.60% | 86.53% | |
45 Neutral | HK$126.27M | ― | -26.83% | ― | -81.56% | 26.00% | |
21 Underperform | HK$18.12M | ― | ― | 16.32% | 57.06% |